Diffuse Cutaneous Systemic Sclerosis

Description

Diffuse cutaneous systemic sclerosis (dcSSc) is a subtype of Systemic Sclerosis (SSc; see this term) characterized by truncal and acral skin fibrosis with an early and significant incidence of diffuse involvement (interstitial lung disease, oliguric renal failure, diffuse gastrointestinal disease, and myocardial involvement).

Clinical Features

Top most frequent phenotypes and symptoms related to Diffuse Cutaneous Systemic Sclerosis

  • Muscle weakness
  • Pain
  • Flexion contracture
  • Hypertension
  • Dysphagia
  • Vomiting
  • Diarrhea
  • Congestive heart failure
  • Renal insufficiency
  • Constipation

And another 26 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Diffuse Cutaneous Systemic Sclerosis Is also known as progressive cutaneous systemic scleroderma, diffuse cutaneous systemic scleroderma, progressive cutaneous systemic sclerosis.

Researches and researchers

Doctors, researchs, and experts related to Diffuse Cutaneous Systemic Sclerosis extracted from public data.

Diffuse Cutaneous Systemic Sclerosis Experts map



Current Researchs and researchers

  • MANCHESTER — Pr Ariane HERRICK

    Investigator of research project

    • Institution/s:
      — Institute of Inflammation and Repair, Faculty of Medical and Human Sciences - University of Manchester
      — Hope Hospital, University of Manchester
    • Research area/topic::

      ESOS: Observational study of early diffuse cutaneous systemic sclerosis


  • SALFORD — Pr Ariane HERRICK

    Investigator of research project

    • Institution/s:
      — Institute of Inflammation and Repair, Faculty of Medical and Human Sciences - University of Manchester
      — Hope Hospital, University of Manchester
    • Research area/topic::

      ESOS: Observational study of early diffuse cutaneous systemic sclerosis



Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Diffuse Cutaneous Systemic Sclerosis Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Comprehensive Pulmonary Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2 , (...)

View the complete list with 73 more genes
Specificity
2 %
Genes
20 %
Arterial Hypertension Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).

BMPR1B, BMPR2, CAV1, ACVRL1, ABCA3, ENG, GDF2, KCNA5, KCNK3, SMAD4, SMAD9
Specificity
10 %
Genes
20 %
Pulmonary Arterial Hypertension Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

BMPR2, CAV1, ACVRL1, ABCA3, ENG, GDF2, KCNA5, KCNK3, SMAD4, SMAD9
Specificity
10 %
Genes
20 %
Partial Lipodystrophy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago (United States).

ZMPSTE24, CAV1, TBC1D4, CIDEC, ADRA2A, AKT2, LIPE, LMNA, LMNB2, PIK3R1, PLIN1, POLD1, PPARG, PSMB8
Specificity
8 %
Genes
20 %
Congenital Generalized Lipodystrophy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago (United States).

CAV1, BSCL2, AGPAT2, FBN1, KCNJ6, CAVIN1
Specificity
17 %
Genes
20 %
Comprehensive Lipodystrophy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago (United States).

ZMPSTE24, CAV1, BSCL2, TBC1D4, CIDEC, ADRA2A, AGPAT2, FBN1, AKT2, KCNJ6, LIPE, LMNA, LMNB2, PIK3R1, PLIN1, POLD1, PPARG, PSMB8, CAVIN1
Specificity
6 %
Genes
20 %
Comprehensive Lipodystrophy Panel.

By Genetic Services Laboratory University of Chicago (United States).

ZMPSTE24, CAV1, BSCL2, TBC1D4, CIDEC, ADRA2A, AGPAT2, FBN1, AKT2, KCNJ6, LIPE, LMNA, LMNB2, PIK3R1, PLIN1, POLD1, PPARG, PSMB8, CAVIN1
Specificity
6 %
Genes
20 %
Congenital Generalized Lipodystrophy Panel.

By Genetic Services Laboratory University of Chicago (United States).

CAV1, BSCL2, AGPAT2, FBN1, KCNJ6, CAVIN1
Specificity
17 %
Genes
20 %

We have 62 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

ORPHANET Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C TOOTH AGENESIS, SELECTIVE, 1; STHAG1 HUNTINGTON DISEASE-LIKE 2; HDL2 ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more